EU-CiP Team

The Berlin Institute of Health at Charité (BIH) is dedicated to biomedical translation: findings from research are translated into approaches for personalised prevention, diagnostics and therapy. The overarching goal is to create relevant benefits for patients. With over 750 employees, the BIH focuses on translational method development, precision medicine and regenerative therapies, including biomedical data sciences.

A particular strength of the BIH is its seamless integration into Charité – Universitätsmedizin Berlin. A combined medical school and university medical centre, Charité ia a leader in diagnosis and treatment of particularly severe, complex, and rare diseases and health conditions. At Charité, people and their health come first and the foremost goal is to actively help shape the medicine of the future.

The Austrian Institute of Technology is Austria’s largest research and technology organisation focusing on two main areas of research: resilient and sustainable infrastructures, particularly in the fields of energy, transport and health, and the digital transformation of industry and society. In doing so, it works closely with universities, industry and public institutions in Austria, Europe and beyond. This creates significant added value through innovation and new technologies.

As an ingenious partner, AIT supports industry and the public sector in technological developments, infrastructure issues and strategic decisions. AIT is active along the entire value chain – from concepts, evaluations, roadmaps and strategic plans to the development of innovative solutions, prototypes, demonstrators and the founding of spin-offs.

BBMRI-ERIC is the European Research Infrastructure for biobanking and biomolecular resources established in 2013 under EU legislation. BBMRI-ERIC enables the development of innovative technology and processes as a cross-domain network that facilitates responsible access to high quality samples, data and biomolecular resources.

We achieve this through multidisciplinary expertise and service provision, scientific excellence, knowledge exchange and partnerships in health and life sciences. BBMRI-ERIC’s vision is simplified as: “Biobanking for a Healthier World”. Its headquarters are in Graz, Austria.

The Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG) is responsible for researching and planning public healthcare in Austria. Established by federal law in 2006, GÖG is a public non-profit limited liability company owned by the Republic of Austria. It serves as the national competence and funding centre for health promotion and supports the continuous improvement of the Austrian healthcare system.

The fields of expertise and services provided by GÖG are extensive, and include structural healthcare planning, health economics, Health Technology Assessment, digital health, mental health, cancer care coordination, long-term care, rehabilitation, and health literacy.

Comunicare Solutions, a spin-off of the University of Liège (Belgium), specialises in the development of digital health solutions. The company develops patient support solution for chronic care, post-hospitalisation care paths, or decentralised clinical trials. Our solutions provide a non-pharmacological strategy for improving disease management at home through patient education and empowerment, remote monitoring, and disease-specific predictive models.

With proven success in different therapeutic areas, our platform improves patient engagement and shared decision with caregivers, optimises treatment pathways, and supports coordinated care across multidisciplinary teams. We aim to revolutionise healthcare by ensuring timely interventions, enhancing quality of life, and driving efficiencies in patient care.

DiCE is a European non-profit umbrella organisation uniting 40 national patient organisations distributed in 32 countries and collaborating with stakeholders dedicated to all digestive cancers. Through advocacy, research, and awareness-raising, we support patients and carers to improve survival and quality of life. As the voice of the digestive cancer community, we champion early diagnosis and equal access to the highest standards of treatment and care for everyone across Europe.

DiCE will be mainly involved in the Patient Engagement Work Package, ensuring that patient needs, perspectives, and experiences are fully integrated throughout the project. This includes reviewing all content to guarantee it is written in clear, accessible, and patient-friendly language.

The European Cancer Organisation (ECO) is the largest non-profit, multi-professional federation in Europe. It brings together hundreds of different professional societies and patient groups to advocate for more effective, efficient, and equitable cancer care.

The Bank of Cyprus Oncology Centre (BOCOC) is a not-for-profit, CHKS-accredited cancer referral centre established in 1998 through a partnership between the Cyprus Government and the Bank of Cyprus. It offers advanced, multidisciplinary cancer care, including diagnostic imaging, radiation therapy (3D-CRT, IMRT, VMAT, IGRT, stereotactic RT, brachytherapy), medical oncology, and clinical trials.

Equipped with state-of-the-art technology such as linear accelerators, MRI, CT, and SPECT-CT, the Centre provides inpatient, outpatient, and day care services in a patient-focused environment. BOCOC’s mission is to serve cancer patients and their families with excellence and compassion. Its vision is to be a leading regional centre committed to innovation, collaboration, and continuous improvement in cancer care.

Cancer Information Service (CIS) at the German Cancer Research Center (DKFZ): The CIS provides independent, evidence-based and up-to-date information on all cancer-related topics. A team of physicians answers individual questions by phone or email, supporting patients, families, the general public and healthcare professionals in making informed decisions.

The CIS’s expertise is grounded in a continuously maintained knowledge database and is ensured through rigorous quality management and ongoing staff training. Operated by the DKFZ — Germany’s leading cancer research institution — the service handles over 25,000 enquiries annually. Additionally, the CIS offers a comprehensive German-language website with reliable information on cancer prevention, diagnosis, treatment and living with cancer, alongside downloadable brochures and fact sheets.

Identity Valley is a German non-profit organisation dedicated to building a trustworthy digital future grounded in universal values, ethical principles, and human rights. Through advocacy, research, and collaboration, Identity Valley promotes human-centric digital transformation, ensuring technologies are transparent, secure, inclusive, and accountable.

Central to its mission are the Digital Responsibility Goals® (DRGs)—a holistic framework akin to the UN’s SDGs, guiding governments, industries, and citizens to create a fair, safe, and value-based digital ecosystem. With its headquarters in Unkel/Rhine and hubs in Cologne, Munich and Brussels Identity Valley fosters digital literacy, privacy, cybersecurity, algorithmic accountability, and human agency – empowering society to shape technology for the common good.

Steinbeis focuses on establishing interoperable standards for the secure and privacy-compliant cross-border exchange of health data to support healthcare and research. The organisation provides technical consulting for the implementation of digital health solutions such as electronic health records (EHRs) and develops secure methods for patient identification.

Key areas of expertise include the comprehensive digitisation of healthcare, development of tailored software solutions, and support for IT projects in medical and clinical research. Building on insights from projects such as Health-X dataLOFT and the European Cancer Patient Portal (ECPDC) implementation study, Steinbeis will contribute its expertise to EU-CIP.

Heidelberg University Hospital (Universitätsklinikum Heidelberg, UKHD) is one of the largest and most prestigious medical centres in Germany. The Medical Faculty of Heidelberg University (Medizinische Fakultät Heidelberg, MFHD) belongs to the internationally renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. Heidelberg University Hospital and the Medical Faculty of Heidelberg University employs around 14.500 employees and is committed to providing trainings and qualifications. Every year, around 86,000 patients and more than 1.100.000 outpatient cases are treated in more than 50 clinical departments with almost 2.500 beds.

Together with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the German Cancer Aid, the UKHD established the first National Center for Tumor Diseases (NCT) in Heidelberg. The goal is to provide care at the highest level as an oncology centre of excellence and to rapidly transfer promising approaches from cancer research to the hospital.

Barcelona Supercomputing Center-Centro Nacional de Supercomputación (BSC-CNS) is the national supercomputing centre in Spain. BSC-CNS is specialised in high performance computing (HPC) and manage MareNostrum 5, one of the most powerful supercomputers in Europe.

The centre manages the Red Española de Supercomputación (RES), and is a hosting member of the Partnership for Advanced Computing in Europe (PRACE) initiative. Also, it actively participates in the main European HPC initiatives. With a total staff of more than 1200 R&D experts and professionals, BSC has been successful in attracting talent, and our research focuses on five fields: Computer Sciences, Life Sciences, Earth Sciences, Computer Applications in Science and Engineering, and Computational Social Sciences and Humanities. Its research lines are developed within the framework of European Union research funding programmes, Spanish and Catalan public research calls and collaborations with leading companies.

Futuro Perfecto Innovation (FPI) is a science & technology consultancy firm composed of PhD scientists, managers, engineers and deep-tech professionals. Operating in over 15 EU countries, as well as the USA and Asia, FPI specialises in innovation and strategic management, delivering expert solutions across a range of research organisations, SMEs and industries. Within FPI, our team displays a diverse array of expertise, including Public Health and Science Communication, as well as PhDs in Physics, Nanoscience, Biomaterials or Biotechnology, alongside Computer Science and Materials Science scientists, and Strategy Formulation.

FPI boasts a proven track record and extensive experience in successfully securing funding from Horizon Europe and other EU programmes, demonstrating expertise in project management, consortia coordination, stakeholder collaboration, and knowledge dissemination. In the EU-CIP project, FPI participates as co-coordinator, as well as partner of the Dissemination & communication work package.

The Aragon Health Sciences Institute (IACS) has research and innovation groups as well as competitive Core Research Facilities to provide access to last generation equipment together with the advice and support of highly trained and specialised professionals: Animal facility, Medical Imaging and Phenotyping, Experimental surgery, Biocomputing, Biobank, Cell culture, Diagnostic Laboratory, Proteomics, Microscopy and Imaging, Sequencing and Functional Genomics as well as Cell separation and cytometry. Since 2018, IACS is responsible for the development and maintenance of BiGAN (computational infrastructure and real world data lake gathering data from Aragon Regional Public Health System) as well as its linkage to national and European networks.

IACS is the Health Technology Assessment (HTA) agency for the Regional Government and is part of the Spanish and International Network of HTA Agencies. IACS holds the secretariat of the national clearinghouse of clinical practice guidelines (GuiaSalud), coordinating the development, dissemination and adoption of evidence-based products for the Spanish National Health System. As part of these activities, IACS leads efforts to incorporate patients into evaluation and implementation processes. Special attention is given to patient-facing materials, which are co-developed or validated to improve comprehension, promote adherence, and support shared decision-making.

The Vall d’Hebron Institute of Oncology (VHIO), founded in 2006, is a leading center for personalized cancer medicine. Its innovative translational and multidisciplinary research model, along with collaboration in international projects, enables rapid transformation of lab discoveries into early clinical trials, offering new patient treatments.

VHIO’s research is structured into Preclinical & Translational, Clinical, and Core Technologies programs, focusing on understanding cancer biology and developing therapies. Its mission is to advance independent, high-quality translational research to improve cancer prevention, diagnosis, and treatment. VHIO aims to be a global leader in cancer research, benefiting patients and society. Its core values include a translational focus, patient-centeredness, excellence, collaboration, ethical commitment, gender equality, and efficient use of resources.

HUPON, as a national collaboration of pediatric oncology centers in Hungary, is dedicated to improving the diagnosis, treatment, and care of children with cancer. Established in 1971, the Hungarian Pediatric Oncology Network (HuPON) coordinates specialized pediatric oncology departments across Hungary, delivering standardized diagnostics and treatments for childhood cancers. Based at the Department of Pediatrics, Semmelweis University, Budapest, HuPON hosts one of Europe’s oldest population-based childhood cancer registries, systematically recording disease characteristics, treatments, outcomes and long-term follow-up data. The Network ensures centralized, high-quality care with modern medical equipment, based on consensus protocols, ongoing specialist education and innovative personalized therapies.

With government-supported initiatives since 2012, HuPON is crucial for monitoring cancer incidence, enhancing patient survival rates, optimizing healthcare strategies and enabling international comparisons, thereby significantly advancing pediatric cancer care nationally and across Europe, reducing inequalities and empowering patients and families through reliable information and dedicated support. Our team is currently working on adapting and implementing the digital survivorship passport in close partnership with Érintettek parent and patient support association.

As a partner in the EUCIP project, HUPON brings its expertise in multidisciplinary pediatric oncology with a focus on developing patient- and family-centered education models that support cross-border access to reliable, understandable, and compassionate cancer-related information.

The Department of Health (Irish: An Roinn Sláinte) is a department of the Government of Ireland. The Department of Health’s mission is to improve the health and wellbeing of people in Ireland by delivering high quality health services and getting best value from health system resources. The department is led by the Minister for Health.

Follow the DoHIE on Twitter/X, LinkedIn and Instagram

The Center for Ethics in Science and Journalism (CESJ) is a non-profit organization established in Milan, Italy, in 2016. Its mission is to promote professional development and raise public awareness about ethical approaches to science, research, and science journalism. CESJ’s governance and staff bring extensive professional and academic expertise in bioethics, research ethics, journalism, science communication and the use of AI in journalism.

The team includes former researchers in molecular oncology, medical doctors, and experienced medical journalists, particularly in cancer reporting. They have collaborated with prominent Italian institutions such as the Italian Association for Cancer Research (AIRC), the Umberto Veronesi Foundation (FUV), and the European School of Oncology (ESO). CESJ leads two work packages focused on ethics and best practices within the FRONTIERS project, funded by the European Research Council (ERC).

The organization has also received support from institutions such as UNESCO and the European Commission’s Joint Research Centre to organize summer schools and workshops on research ethics for science journalists and researchers. Additionally, it has collaborated with the Fondazione Compagnia di San Paolo on a project dedicated to scientific citizenship.

Lithuanian University of Health Sciences (LSMU) is the largest institution of higher education for biomedical sciences in Lithuania, successfully integrating studies, research, and clinical practice. Located in Kaunas, LSMU was established in 2010 through the merger of Kaunas University of Medicine and the Lithuanian Veterinary Academy, LSMU unites faculties of Medicine, Pharmacy, Odontology, Nursing, Public Health, Veterinary Medicine, and Animal Science.

Its flagship hospital—Kauno klinikos—is the largest and most advanced healthcare institution in the Baltic States. With over 8,000 students from 88 countries and academic partnerships with more than 140 universities worldwide, LSMU is an international hub for medical education. Actively participating in Erasmus+ and serving as a World Health Organization Collaborating Centre, LSMU contributes to health policy-making at both national and international levels, reinforcing its role in shaping the future of healthcare and public health.

POLA is the largest cancer patient organization in Lithuania, providing essential social support, representing patient interests, and actively contributing to the development of health and social policies at both national and EU levels.

The association brings together 30 member NGOs and unites a community of 57,000 cancer patients – POLA cardholders who have applied for membership and are registered in the POLA database. The POLA card provides access to a range of services, discounts, and support tailored to the specific needs of cancer patients.

POLA’s mission is to improve the quality of life for people affected by cancer and their families. It seeks to ensure that every patient receives not only timely and effective medical treatment but also continuous access to reliable information, emotional support, social services, and psychological care throughout their journey.

The State Data Agency (SDA) is one of the partners of the project. SDA is an institution of the Government of the Republic of Lithuania which participates in the formation of the state policy in the field of official statistics management assigned to the Minister of Finance as well as in the field of state data management, and which implements this policy and coordinates the production of official statistics pursuant to the provisions of Part I of the Official Statistics Programme, and the management of state data – pursuant to the State Data Governance Programme.

State Data management and processing is concentrated in one place – the State Data Governance Information System (SDG IS). SDG IS or State Data Lake is a system managed by the State Data Agency (Statistics Lithuania), designed to manage and accumulate state data, provide information prepared on the basis of these domains during the monitoring and analysis of the state’s economic and social development, and ensure effective information exchange between public sector institutions.

ITTM is specialised in data and knowledge management for preclinical, clinical, and real-world data. We offer interwoven services and solutions to enhance data quality, refine data models, establish a knowledge platform, and provide secure hosting for clinical research and digital health. Founded in 2015, ITTM is strongly and actively involved in numerous IHI projects.

ITTM is actively involved in all aspects of data management, data sharing, and supports projects with process understanding and optimization of workflows (strong focus on interoperability aspects). ITTM is actively contributing to the implementation of the FAIR principles and federated analysis using the OMOP-CDM. The mission of ITTM is Making Data Actionable, thus enabling and facilitating secure and federated data analysis (and AI).

The Luxembourg Institute of Health (LIH) is a public biomedical research organization focused on precision health and invested in becoming a leading reference in Europe for the translation of scientific excellence into meaningful benefits for patients.

LIH places the patient at the heart of all its activities, driven by a collective obligation towards society to use knowledge and technology arising from research on patient derived data to have a direct impact on people’s health. Its dedicated teams of multidisciplinary researchers strive for excellence, generating relevant knowledge linked to immune related diseases and cancer.

The institute embraces collaborations, disruptive technology and process innovation as unique opportunities to improve the application of diagnostics and therapeutics with the long-term goal of preventing disease.

Established in 2015 under Luxembourg’s first National Cancer Plan, the National Cancer Institute (INC) operates under the mandate and funding of the Ministry of Health and Social Security. Its mission is to coordinate, plan, and improve the national response to cancer.

The INC supports prevention, diagnosis, treatment, and follow-up by working with healthcare professionals, researchers, education professionals, and patients to promote high-quality, equitable, evidence-based care.

It plays a key role in the second National Cancer Plan, coordinates the development of clinical guidelines, patient pathways, and national tumour boards for rare and complex cases. The INC also leads patient information efforts, including a national information platform, and contributes to public awareness. With a patient-centered, innovation-driven approach, it aims to reduce the impact of cancer across Luxembourg.

The Cancer Research and Innovation Hub Malta (CRIHM), launched in 2024, is the national platform coordinating cancer research and innovation. It serves as Malta’s National Cancer Mission Hub, aligning with the EU Cancer Mission.

CRIHM promotes cross-sector collaboration between researchers, healthcare professionals, policymakers, and civil society. It supports research in molecular diagnostics, therapeutics, and psychosocial care, and funds innovative projects through its national cancer research programme. CRIHM also runs a Mobile Education Unit to raise public awareness on cancer prevention across Malta and Gozo and is among the first certified National Cancer Mission Hubs in Europe.

Health-RI is a public-private partnership of organizations involved in health research and care. It’s mission is to build an integrated health data research infrastructure accessible for researchers, citizens and care providers and facilitate and foster the optimal use of knowledge, tools, facilities, health data and samples to enable a learning healthcare system and accelerate sustainable and affordable personalized medicine and health.

Health-RI coordinate the CANDLE project (National CAncer data Node DeveLopErs) (the link to the CANDLE webpage can be added when ready) which supports the development of National Cancer Data Node across Europe in alignment with EHDS national implementation.

The Institute for Cancer Genetics and Informatics (ICGI) at Oslo University Hospital, merges cutting edge biomedicine and artificial intelligence with deep learning to revolutionise cancer diagnostics and prognostics.

Their interdisciplinary team focus research and development on computational pathology and the development of accurate and robust prognostic and predictive markers. They have more than 20 years experience with the development and maintenance of web solutions with information about cancer and cancer treatment, involving expert clinicians for each cancer type. The website kreftlex.no is made for cancer patients and their relatives, and previously they developed and maintained oncolex.no with information.

Evidence Prime is a software development company specializing in scientific information management and evidence-based decision-making. We are focused on creating machine learning and natural language processing solutions to automate and streamline the research process and improve the efficiency of evidence synthesis. Key products include:

GRADEpro: A world-leading toolkit that streamlines every stage of medical guideline creation, from evidence assembly to final dissemination. It is trusted by more than 150 thousand users and numerous global organizations.

Laser AI: A comprehensive system for automating systematic reviews. Laser AI significantly streamlines evidence synthesis for healthcare decision-making.

RecChat: An AI-powered chatbot that enhances access to healthcare information. It was first created as a conversational search engine for the eCOVID-19 RecMap, providing users with precise, fact-based answers to questions in natural language.

The Portuguese Health Literacy Society (SPLS), constituted on January 19, 2022, was proposed and has since been developed under the dynamic leadership of Professor Cristina Vaz de Almeida, its current President. Recognized nationally and across Europe as a leading reference in health literacy promotion, SPLS is a scientific and educational non-profit association committed to empowering citizens and professionals to make informed health decisions.

The Society pursues scientific, educational, technical, organizational, ethical, and human objectives. It leads projects such as “From Step to Embrace,” aimed at increasing longevity in older adults with cancer, alongside producing eBooks on prostate and colorectal cancer. SPLS participates in European initiatives like EU-CIP, CHOICE, and HYGIEIA, strengthening cancer prevention and self-care efforts. The organization also conducts webinars, contests, events, and awareness campaigns on health key topics. Through partnerships and participation in summits and scientific councils, SPLS advocates for equity in health information access, contributing to healthier and empowered societies.

Youth Cancer Europe is a pan-European, impact-driven patient advocacy network, representing young people aged 18-39 from 40+ European countries with a track record of shaping EU policies on cross-border healthcare, financial discrimination, fertility preservation, reproductive rights, mental health and health equity; influencing legislative changes EU-wide as well as on the local level across different healthcare systems, with a keen focus on supporting the needs of marginalised, minority and protected populations across the EU.

The Institute of Oncology “Prof. Dr. Ion Chiricuță” Cluj-Napoca (IOCN) is a leading comprehensive cancer center in Romania, recognized nationally and internationally for excellence in oncology care, research, and education.

IOCN provides preventive, curative and palliative medical services in the field of oncology and it is committed to innovation, digital transformation, and collaboration at European level to improve cancer prevention, early detection, and patient outcomes. IOCN also contributes to shaping health policies and strengthening oncology networks across the EU.

The Centre for Innovation in Medicine (INOMED) is a European research and innovation organization (Romanian NGO) dedicated to accelerating the application of medical innovations for public benefit. Focused on innovative health policy, strategic communication, and civil society education, INOMED serves as an independent platform for multi-stakeholder dialogue across cancer, omics medicine, personalized healthcare, digital health, and other emerging fields.

The organization engages in adult education projects aimed at improving public health literacy—leading the 4P-CAN initiative on cancer prevention in rural areas and contributing to RethinkHPV, PERFECTO, and GUIDE.MRD, which address HPV vaccination, familial hypercholesterolemia, and personalized diagnostics. By combining scientific insight with community-driven outreach, INOMED empowers individuals to make informed decisions and fosters early adoption of health innovations.

The Swedish Network against Cancer – Nätverket mot cancer (NMC) is an umbrella organisation for cancer-related patient organisations in Sweden. Our vision: A community free from Cancer. NMC brings the patient´s perspective in all activities and works for implementing shared decision-making at all levels. NMC organizes training for patients and researchers for developing informed patients and patient partnership and in “patient-literacy” for research and health care.

Skåne University Hospital Comprehensive Cancer Centre (SUHCCC) is a certified Comprehensive Cancer Centre based in southern Sweden. It represents a strategic collaboration between Skåne University Hospital, Lund University, Regional Cancer Centre South, Medical Services, and the Mobile Teams and Specialized Palliative Care. The organization is based on the existing structure of all partners and all areas are represented in the SUHCCC Board. Collaboration with patients and relatives at different levels within SUHCCC is a prerequisite for achieving the vision.

The six Regional Cancer Centres (RCC) since 2010 aim to support Sweden’s 21 regions in improving the quality, efficiency and care outcomes, aligning with the national cancer strategy and the EU’s cancer plan. The Confederation of Regional Cancer Centres is the national hub for coordinating RCCs and the regions’ implementation efforts via local, regional and national structures. A central assignment is to produce evidence-based national knowledge support, e.g. clinical guidelines, quality registries and My Care Plan. My care plan ensures patients anywhere in Sweden receive equivalent, high-quality information throughout the cancer trajectory, regardless of age, gender and socio-economic status.

The evidence-based content is published by RCC after being processed through a network of clinical experts and adapted to the target group. Various interactive components enhance self-care, patient empowerment, coordination and continuity of care. My care plan is co-created by the patient and the care provider at diagnosis and updated whenever necessary. My care plan is offered digitally by secure login via the national 1177 platform. It is not a medical record.

The Institute of Oncology Ljubljana, founded in 1938, is the principal state institution for comprehensive cancer treatment in Slovenia, with a modern and multidisciplinary approach. Approximately 70 % of all cancer patients in Slovenia are treated at the Institute. It is also the central Slovenian institution for educational and research in oncology and an important oncology center in the region with numerous international connections. The Institute guides the development of a comprehensive cancer care programs in prevention, early detection, diagnosis, treatment, rehabilitation, palliative care, research and education.

Our fundamental mission is to limit the burden of cancer in Slovenia with reducing the increasing rate of cancer incidence, decreasing cancer mortality, increasing the survival rate of cancer patients, and improving the quality of their lives. The Institute is the holder of Slovenian National Cancer Control Program. It manages very successfully national cervical and breast cancer screening programs, ZORA and DORA. Each day more than 1,200 people come through our doors, supported by more than 1,300 staff dedicated to delivering optimal cancer care.

The Cancer Patients’ Association of Slovenia (CPAS) is a humanitarian organization that brings together cancer patients, volunteers, and professionals to improve the lives of those affected by cancer. Guided by a council of expert oncologists, CPAS promotes active patient involvement and the principle of self-help—connecting individuals with shared experiences to offer mutual support, empathy, and understanding. To complement medical treatment, trained volunteers—many of them former patients—provide peer support in hospitals and lead over 20 support groups across Slovenia.

The association raises awareness, informs patients of their rights, and encourages them to actively engage in their treatment and recovery. It also publishes the Okno (The Window) bulletin, featuring expert articles and personal stories. CPAS actively participates in national and international awareness campaigns, including World Cancer Day and Pink October.

ELIXIR is a European research infrastructure which manages and safeguards the massive amounts of life science data and tools being generated by publicly-funded research. We are a network of scientific and technical experts working together to coordinate, integrate and sustain bioinformatics resources, providing access to high-quality data, tools, standards, compute and training. These open resources enable researchers to access and analyse life science data to accelerate research and its impact on society.

Érintettek Parents’ Association for the families involved in childhood cancer. We, the founders of the Association are mainly parents of children cured from childhood cancer or leukemia. We teamed up in 2016 and formed Érintettek Association because we felt we wanted to give something back from the great support we had received. There is no English equivalent for the word Érintettek. Perhaps the word involved, or the phrase touched one is the closest.

The Association is proud to include parents, survivors, doctors, nurses, psychologists, psychotherapists, social workers and even affected civilians, but one thing is common: everyone does their work on a total charity basis. We try to provide high-quality information that are 100% in line with the official medical and professional points of view through several projects, including information books for parents, children and young survivors, an informative website, a newly completed medical Hungarian dictionary, and informative short films and podcasts with young survivors and healthcare professionals.

MedicalScan was founded in 2008 in Hungary with the goal of supporting evidence-based healthcare through data-driven insights. Starting with health data analysis, the company quickly grew into a regional expert in real-world data (RWD) and real-world evidence (RWE) solutions. Over the years, MedicalScan has collaborated with healthcare providers, pharmaceutical companies, and policymakers to improve patient outcomes and healthcare efficiency across Central and Eastern Europe.

In addition to its core work in RWE, MedicalScan has actively contributed to several European Union projects aimed at improving public health and education. These include INHEAL, focused on health literacy, and SOCIALL, supporting the education of social workers. MedicalScan is also a member of EHDEN, the European Health Data & Evidence Network, further strengthening its role in international RWE collaboration and standards. As part of EUCIP project, Medicalscan brings its expertise in developing innovative patient education tools, with the goal of enhancing health literacy, supporting prevention, and empowering individuals to take an active role in their care across Europe.